Journal ArticleOPEN ACCESS

Systemic Botulism Toxicity Caused by Pyloric Botox Injection to Treat Gastroparesis

Case Reports in Gastroenterology (2020) 14(2) 373-376
DOI: 10.1159/000508854
4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Systemic botulism resulting from therapeutic Botox (OnabotulinumtoxinA) injection has been rarely reported, and never in the context of pylorus injection to treat gastroparesis. We report the case of a 27-year-old female with Emery-Dreifuss muscular dystrophy who developed severe systemic botulism toxicity following the intrapyloric injection of 100 units of Botox to treat gastroparesis. The patient eventually made a full recovery.

Author supplied keywords

Cite

CITATION STYLE

APA

Bensen, G. P., Rutherford, C. C., & Gardner, T. B. (2020). Systemic Botulism Toxicity Caused by Pyloric Botox Injection to Treat Gastroparesis. Case Reports in Gastroenterology, 14(2), 373–376. https://doi.org/10.1159/000508854

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free